Mtb-IN-4 exhibits anti-Mycobacterium tuberculosis (Mtb) activity (IC50 = 0.70 μM); it inhibits respiration and biofilm formation of Mtb within macrophages and enhances the inhibitory effect of the antibiotic isoniazid (INH) against INH-resistant Mtb mutants.